Literature DB >> 7251300

Autoregulation of retinal circulation in response to decrease of perfusion pressure.

C E Riva, S H Sinclair, J E Grunwald.   

Abstract

Autoregulation of the retinal circulation in response to an acute elevation of intraocular pressure was investigated in 17 subjects (23 eyes) with no ocular abnormalities, by means of the blue field entoptic phenomenon. This phenomenon allows a person to observe leukocytes flowing in his own macular capillaries. Subjects were instructed to compare the speed of their leukocytes in one eye with that in the other eye. All subjects perceived equal speed in both eyes. During their observation of the leukocytes, the intraocular pressure (IOP) was rapidly raised in one eye to a level at which autoregulation was not sufficient to maintain normal blood flow. At that level of IOP, subjects described the leukocytes moving slower in this eye than in the fellow eye. The IOP was then decreased in steps of 2 to 3 mm Hg until the subjects reported observing equal leukocyte speeds in both eyes. The IOP at which this occurred, IOPmax, represents the highest IOP (lowest mean perfusion pressure P min) at which the retina is able to maintain normal blood average IOPmax was 29.6 +/- 2.0 mm Hg, corresponding to an average of P min of 27 +/- 6 min Hg and demonstrating that a decrease of 36% or less in perfusion pressure is adequately compensated by retinal vascular autoregulation.

Entities:  

Mesh:

Year:  1981        PMID: 7251300

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  58 in total

1.  Effect of oral felodipine on ocular circulation.

Authors:  L S Schocket; J E Grunwald; J Dupont
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

2.  Autoregulative behavior of retinal arteries and veins during changes of perfusion pressure: a clinical study.

Authors:  Edgar Nagel; Walthard Vilser
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-25       Impact factor: 3.117

3.  Retinal vessel autoregulation in sickle cell patients.

Authors:  J C van Meurs; J Schwoerer; B Schwartz; P G Mulder; H J Meiselmann; C S Johnson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

4.  [Color Doppler sonography of retrobulbar vessels and hypercapnia in normal tension glaucoma].

Authors:  N Plange; M Bienert; A Harris; A Remky; K O Arend
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

5.  Lack of correlation between short-term dynamics of diabetic retinopathy lesions and the arterial blood pressure.

Authors:  Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-03       Impact factor: 3.117

6.  Autoregulation of human optic nerve head blood flow in response to acute changes in ocular perfusion pressure.

Authors:  C E Riva; M Hero; P Titze; B Petrig
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

Review 7.  Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

Authors:  Niall Patton; Tariq Aslam; Thomas Macgillivray; Alison Pattie; Ian J Deary; Baljean Dhillon
Journal:  J Anat       Date:  2005-04       Impact factor: 2.610

8.  Strict control of glycaemia: effects on blood flow in the large retinal vessels and in the macular microcirculation.

Authors:  J E Grunwald; C E Riva; B L Petrig; A J Brucker; S S Schwartz; S N Braunstein; J DuPont; S Grunwald
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

9.  Acute effect of metipranolol on the retinal circulation.

Authors:  S Wolf; E Werner; K Schulte; M Reim
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

10.  Blood pressure, perfusion pressure, and open-angle glaucoma: the Los Angeles Latino Eye Study.

Authors:  Farnaz Memarzadeh; Mei Ying-Lai; Jessica Chung; Stanley P Azen; Rohit Varma
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.